Cognition Therapeutics
CGTX
CGTX
31 hedge funds and large institutions have $13.9M invested in Cognition Therapeutics in 2022 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
9.2% more ownership
Funds ownership: 22.96% → 32.16% (+9.2%)
Holders
31
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$4.2M | |
| 2 | +$627K | |
| 3 | +$190K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$123K |
| 5 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
+$95K |
Top Sellers
| 1 | -$407K | |
| 2 | -$254K | |
| 3 | -$214K | |
| 4 |
VC
Voss Capital
Houston,
Texas
|
-$172K |
| 5 |
PWM
Perigon Wealth Management
San Francisco,
California
|
-$163K |